PIK3CA mutation status in Japanese lung cancer patients
Authors:
- Hidefumi SasakiHSHidefumi Sasaki
- Katsuhiko EndoKEKatsuhiko Endo
- Eriko SuzukiESEriko Suzuki
- Hiroshi HanedaHHHiroshi Haneda
- Haruhiro YukiueHYHaruhiro Yukiue
- Yoshihiro KobayashiYKYoshihiro Kobayashi
- Motoki YanoMYMotoki Yano
- Yoshitaka FujiiYFYoshitaka Fujii
- 1 November 2006
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 54 (2) , 209-215
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagusInternational Journal of Cancer, 2006
- Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell linesBiochemical and Biophysical Research Communications, 2006
- Mutation of the PIK3CA oncogene in human cancersBritish Journal of Cancer, 2006
- EGFR and erbB2 mutation status in Japanese lung cancer patientsInternational Journal of Cancer, 2005
- EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCyclerClinical Cancer Research, 2005
- PIK3CA mutations in advanced ovarian carcinomasHuman Mutation, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and MedulloblastomasCancer Research, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example*Molecular Diagnosis, 1999